Who has invested in TriArm Therapeutics?

Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金 are named among the investors backing TriArm Therapeutics.

TriArm Therapeutics Funding: $60M Raised, Series A (2021)

TriArm Therapeutics funding overview

TriArm Therapeutics is based in Shanghai, China. TriArm Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for TriArm Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金 and 1 others. 7 distinct backers are named across the disclosed rounds.

TriArm Therapeutics at a glance

Total raised: $60M
Latest round: Series A
Latest round date: September 2021
Headquarters: Shanghai, China
Notable investors: Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金, 瑞伏医疗健康基金

Frequently asked about TriArm Therapeutics funding

How much has TriArm Therapeutics raised?: TriArm Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in TriArm Therapeutics?: Panacea Venture, VI Venture, HT Capital, Efung Capital, LO Co-Investment Fund, 金浦健康基金 are named among the investors backing TriArm Therapeutics.
What was the latest TriArm Therapeutics funding round?: The most recent disclosed round is a Series A, announced in September 2021.
Where is TriArm Therapeutics based?: TriArm Therapeutics is based in Shanghai, China.
When did TriArm Therapeutics last raise?: The last disclosed TriArm Therapeutics round closed in September 2021 at Series A.

Round data for TriArm Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

TriArm Therapeutics Funding: $60M Raised, Series A (2021)

TriArm Therapeutics funding overview

TriArm Therapeutics at a glance

Frequently asked about TriArm Therapeutics funding

Companies related to TriArm Therapeutics (27)

Browse related funding lists (6)